prednisolone has been researched along with Aberrant Tissue in 2 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahrengart, L | 1 |
Lindgren, U | 1 |
Reinholt, FP | 1 |
Dufour, JP | 1 |
Lachapelle, JM | 1 |
Nagant de Deuxchaisnes, C | 1 |
Devogelaer, JP | 1 |
Noel, H | 1 |
Maldague, B | 1 |
2 other studies available for prednisolone and Aberrant Tissue
Article | Year |
---|---|
Comparative study of the effects of radiation, indomethacin, prednisolone, and ethane-1-hydroxy-1,1-diphosphonate (EHDP) in the prevention of ectopic bone formation.
Topics: Animals; Bone and Bones; Choristoma; Drug Evaluation, Preclinical; Etidronic Acid; Immobilization; I | 1988 |
Cutaneous mucinosis associated with multiple frozen joints and bony heterotopic deposits around the hips.
Topics: Adult; Anti-Inflammatory Agents; Bone and Bones; Choristoma; Hip; Humans; Hydroxychloroquine; Joint | 1986 |